Professor Larry Gold to Receive a Lifetime Achievement Award at Aptamers 2021
By: Colorado BioScience Association Date: 04/14/2021
We are delighted that Professor Larry Gold will receive a Lifetime Achievement Award on behalf of the International Society on Aptamers (INSOAP) for his pioneering and extraordinary contributions to t...
Learn MoreCogent Biosciences Announces Creation of Cogent Research Team
By: Colorado BioScience Association Date: 04/14/2021
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the formation of the Cogent Research Team l...
Learn MoreAlan Greene Joins Securisyn Medical, LLC as Chief Marketing Officer
By: Colorado BioScience Association Date: 04/13/2021
Securisyn Medical LLC, (“Securisyn” or the “Company”), is pleased to announce that Alan (Al) Greene has joined the Company as its Chief Marketing Officer, effective April 1st, 2021. Securisyn Medical,...
Learn MoreTriSalus Life Sciences and MD Anderson Announce Strategic Research Collaboration to Evaluate Treatment of Solid Tumors
By: Colorado BioScience Association Date: 04/08/2021
The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences®, an emerging immuno-oncology company committed to transforming outcomes for patients with liver and pancreatic tumors, tod...
Learn MoreApplied Spectral Imaging and KromaTiD Announce Strategic Commercial Partnership
By: Colorado BioScience Association Date: 04/07/2021
Applied Spectral Imaging (ASI) and KromaTiD, Inc. announced today that they have entered into a strategic commercial partnership, granting ASI worldwide rights to market KromaTiD’s proprietary Pinpoin...
Learn MoreInscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing
By: Colorado BioScience Association Date: 04/05/2021
Inscripta, Inc., the digital genome engineering company, today announced the first commercial shipment of its Onyx™ platform and the closing of a $150 million Series E financing round led by Fide...
Learn MoreCU Anschutz Schools and Colleges Rank Among Nation’s Best in 2022 U.S. News & World Report Listing
By: Colorado BioScience Association Date: 03/31/2021
The University of Colorado School of Medicine has moved up in rankings for primary care and research; first time in top 30 for research. Colorado School of Public Health makes Top 20 best programs in...
Learn MoreSomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform
By: Colorado BioScience Association Date: 03/29/2021
SomaLogic, a global leader in proteomics technology, powered by a proprietary platform, the largest clinical proteomic database and next generation artificial intelligence and machine learning, and CM...
Learn MoreEdgewise Therapeutics Announces Pricing of Initial Public Offering
By: Colorado BioScience Association Date: 03/26/2021
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, announced today t...
Learn MoreAytu BioScience Announces Close of Merger with Neos Therapeutics
By: Colorado BioScience Association Date: 03/22/2021
Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced the closing of its merger with N...
Learn More